Search The Medical Knowledge Base

Search:

Medical News by Category

Multiple Sclerosis News

• BG-12 (Biogen) is filed at FDA and EMA for Multiple Sclerosis
  

  Published: Friday 11 May 2012

• Additional data from CARE-MS II trial of Lemtrada (Genzyme) in Multiple Sclerosis treatment
  

  Published: Tuesday 24 April 2012

• CHMP recomends heart monitoring for Gilenya (Novartis) patients
  

  Published: Friday 20 April 2012

• ONO 4641 success In Phase II trial for Multiple Sclerosis
  

  Published: Wednesday 18 April 2012

• Gilenya (Novartis) toxicity problems issue
  

  Published: Friday 06 April 2012

• ALLEGRO trial of laquinimod reported in NEJM
  

  Published: Sunday 18 March 2012

• NICE recommends Gilenya (Novartis) for Multiple Sclerosis
  

  Published: Friday 16 March 2012

• Biogen Idec files BG-12 at FDA for Multiple Sclerosis
  

  Published: Wednesday 29 February 2012

• Avonex Pen (Biogen Idec) is FDA approved for relapsing Multiple Sclerosis
  

  Published: Wednesday 29 February 2012

• Tysabri(Biogen IDEC/Elan) enters Phase III ASCEND trial for Secondary Progressive Multiple Sclerosis
  

  Published: Sunday 29 January 2012

• Rebif (Merck Serono) is EU approved for Early Multiple Sclerosis
  

  Published: Thursday 26 January 2012

• FDA label change for Tysabri (Biogen IDEC) for Multiple Sclerosis and approval of JCV antibody test
  

  Published: Sunday 22 January 2012

• Gilenya(Novartis) patients with Multiple Sclerosis to be monitored after first dosing
  

  Published: Saturday 21 January 2012

• Aubagio (Sanofi/Genzyme) results in TENERE trial for Multiple Sclerosis
  

  Published: Tuesday 20 December 2011

• Gilenya (Novartis) shows reduction in relapse rates in Phase III Multiple Sclerosis study 2309
  

  Published: Thursday 15 December 2011

• NICE does not recommend Gilenya(Novartis) for Relapsing Remitting Multiple Sclerosis
  

  Published: Thursday 01 December 2011

• Lemtrada(Genzyme/Sanofi) superior to Rebif in CARE-MS II Multiple Sclerosis study
  

  Published: Monday 14 November 2011

• Teva will not file laquinimod at the FDA for Multiple Sclerosis in the immediate future
  

  Published: Friday 04 November 2011

• CONFIRM trial positive for BG-12 in Multiple Sclerosis
  

  Published: Wednesday 26 October 2011

• Lemtrada success over Rebif in CARE-MS 1 trial for Multiple Sclerosis
  

  Published: Saturday 22 October 2011

• Aubagio from Genzyme/Sanofi is filed at FDA for relapsing Multiple Sclerosis
  

  Published: Saturday 22 October 2011

• Aubagio reduces significant relapses in patients with Multiple Sclerosis
  

  Published: Saturday 22 October 2011

• BG-12 results from DEFINE study in Multiple Sclerosis will be presented by Biogen at ECTRIMS and ACTRIMS conference
  

  Published: Friday 21 October 2011

• Lemtrada and Aubagio trials to report at ECTRIMS/ACTRIMS congress
  

  Published: Tuesday 18 October 2011

• Tysabri shows benefits in Multiple Sclerosis patients
  

  Published: Friday 07 October 2011

• TEMSO study for Aubagio in Multiple Sclerosis is published in NEJM
  

  Published: Wednesday 05 October 2011

• FDA refuses approval for new Copaxone indication
  

  Published: Wednesday 05 January 2011